Perspectum
PrivateLast Round
Grant
Nov 14, 2024
Total Funding Raised
$111.63M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Perspectum is a healthtech company that provides AI-driven medical imaging software and non-invasive diagnostic solutions for patients with liver disease, diabetes, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Clinical Trials, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Perspectum Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Perspectum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 14, 2024 | ||||
| Series C | Mar 15, 2023 | ||||
| IPO Announced | Aug 6, 2021 | ||||
| Series B | Apr 14, 2020 | ||||
| Grant | Apr 16, 2019 | ||||
Grant | Jan 1, 2019 |
Key People
Founding team and executive leadership
Perspectum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Barclays PLC | IPO |
| Eureka Network | Grant |
| Oxford Science Enterprises | Series B |
| Westgrove Partners | Series B |
| British Patient Capital | Series C |
| University of Oxford | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Maintains ISO 13485 and EU MDR certifications for SaMD products.
- Jan 9, 2026
Partnering with Oxford University Hospitals NHS Trust for a diagnostic centre.
Perspectum Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Perspectum's valuation, stock price, and market status.